Pegfilgrastim biosimilar (Accord Healthcare)

培非格司亭生物类似药 (Accord Healthcare)

Report date: 2025/03/13 17:40:04

Base Information

Drug NamePegfilgrastim biosimilar (Accord Healthcare)

Drug Alias Name培非司亭生物仿制药 (Accord Healthcare)培非拉司亭生物仿制药 (Accord Healthcare)培非格司亭生物仿制药 (Accord Healthcare)非格司亭生物仿制药 (Accord Healthcare)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsFebrile NeutropeniaNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesAccord Healthcare

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsFebrile NeutropeniaNeutropenia

Inactive IndicationsN/A

ATC CodeL03AA13